What development phase is Megalone in?

Megalone is FDA-approved (marketed).

What is the generic name of Megalone?

FLEROXACIN is the generic (nonproprietary) name of Megalone.

Last reviewed 2026-04-20 · How we verify

Megalone (FLEROXACIN)

FDA-approved active Small molecule Quality 19/100

At a glance

Generic name	FLEROXACIN
Drug class	fleroxacin
Target	DNA gyrase subunit A
Modality	Small molecule
Therapeutic area	Infectious Disease
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Megalone CI brief — competitive landscape report
Megalone updates RSS · CI watch RSS